– Bloomberg
Reata Pharmaceuticals: Q3 Earnings Insights
Reata Pharmaceuticals (NASDAQ:RETA) reported its Q3 earnings results on Monday, November 8, 2021 at 08:00 AM.
Here's what investors need to know about the announcement.
Related Posts
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
Gene therapy startup Dyno Therapeutics Inc has partnered with pharmaceutical giants such as Novartis AG (NYSE: NVS) and Roche Holdings AG (OTC: RHHBY).
LivaNova Q1 Adj. EPS $0.48, Inline, Sales $240.20M Beat $231.57M Estimate
LivaNova (NASDAQ:LIVN) reported quarterly earnings of $0.48 per share which met the analyst consensus estimate. This is a 37.14 percent increase over earnings of $0.35 per share from the same period last year. The
B of A Securities Downgrades Sherwin-Williams to Neutral, Lowers Price Target to $292
B of A Securities analyst Steve Byrne downgrades Sherwin-Williams (NYSE:SHW) from Buy to Neutral and lowers the price target from $313 to $292.